{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:14:23Z","timestamp":1791850463928,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T00:00:00Z","timestamp":1282521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Breast cancer is the most common form of malignancy affecting women worldwide. It is also the leading cancer in females in Cyprus, with approximately 400 new cases diagnosed annually. It is well recognized that genetic variation as well as environmental factors modulate breast cancer risk. The main aim of this study was to assess the strength of associations between recognized risk factors and breast cancer among Cypriot women. This is the first epidemiological investigation on risk factors of breast cancer among the Cypriot female population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We carried out a case-control study, involving 1,109 breast cancer patients and a group of 1,177 controls who were recruited while participating in the National screening programme for breast cancer. Information on demographic characteristics and potential risk factors were collected from both groups during a standardized interview. Logistic regression analysis was used to assess the strength of the association between each risk factor and breast cancer risk, before and after adjusting for the possible confounding effect of other factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In multivariable models, family history of breast cancer (OR 1.64, 95% CI 1.23, 2.19) was the strongest predictor of breast cancer risk in the Cypriot population. Late menarche (OR 0.64, 95% CI 0.45, 0.92 among women reaching menarche after the age of 15 vs. before the age of 12) and breastfeeding (OR 0.74, 95% CI 0.59, 0.92) exhibited a strong protective effect. In the case of breastfeeding, the observed effect appeared stronger than the effect of pregnancy alone. Surprisingly, we also observed an inverse association between hormone replacement therapy (HRT) although this may be a product of the retrospective nature of this study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Overall the findings of our study corroborate with the results of previous investigations on descriptive epidemiology of risk factors for breast cancer. This investigation provides important background information for designing detailed studies that aim to improve our understanding of the epidemiology of breast cancer in the Cypriot population, including the study of gene-environment interactions. Furthermore, our study provides the first scientific evidence for formulating targeted campaigns for prevention and early diagnosis of breast cancer in Cyprus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-10-447","type":"journal-article","created":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T06:14:29Z","timestamp":1282630469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["An investigation of breast cancer risk factors in Cyprus: a case control study"],"prefix":"10.1186","volume":"10","author":[{"given":"Andreas","family":"Hadjisavvas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A","family":"Loizidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicos","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Papachristoforou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kakouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Malas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiola","family":"Marcou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriacos","family":"Kyriacou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,23]]},"reference":[{"key":"2246_CR1","first-page":"572","volume-title":"Harrison's Principles of Internal Medicine","author":"ME Lippman","year":"2001","unstructured":"Lippman ME: Breast cancer. Harrison's Principles of Internal Medicine. Edited by: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. 2001, New York City: McGraw-Hill Professional Publishing, 572-15","edition":"15"},{"key":"2246_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.epirev.a036118","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Horn-Ross PL: Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev. 1993, 15: 7-16.","journal-title":"Epidemiol Rev"},{"key":"2246_CR3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/oxfordjournals.aje.a117079","volume":"139","author":"B Rosner","year":"1994","unstructured":"Rosner B, Colditz GA, Willett WC: Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol. 1994, 139: 819-835.","journal-title":"Am J Epidemiol"},{"key":"2246_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00008469-199502000-00002","volume":"4","author":"I Lipworth","year":"1995","unstructured":"Lipworth I: Epidemiology of breast cancer. Eur J Cancer Prev. 1995, 4: 7-30. 10.1097\/00008469-199502000-00002.","journal-title":"Eur J Cancer Prev"},{"key":"2246_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","volume":"2","author":"TJ Key","year":"2001","unstructured":"Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. The Lancet Oncology. 2001, 2: 133-140. 10.1016\/S1470-2045(00)00254-0.","journal-title":"The Lancet Oncology"},{"key":"2246_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322\/canjclin.55.2.74.","journal-title":"CA Cancer J Clin"},{"key":"2246_CR7","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1186\/bcr605","volume":"5","author":"M Wrensch","year":"2003","unstructured":"Wrensch M, Chew T, Farren G, Barlow J, Belli F, Clarke C, Erdmann CA, Lee M, Moghadassi M, Peskin-Mentzer R, Quesenberry CP, Souders-Mason V, Spence L, Suzuki M, Gould M: Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Research. 2003, 5: R88-102. 10.1186\/bcr605.","journal-title":"Breast Cancer Research"},{"key":"2246_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994, 266: 66-71. 10.1126\/science.7545954.","journal-title":"Science"},{"key":"2246_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995, 378: 789-792. 10.1038\/378789a0.","journal-title":"Nature"},{"key":"2246_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","volume":"321","author":"K McPherson","year":"2000","unstructured":"McPherson K, Stell CM, Dixon JM: ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ. 2000, 321: 624-628. 10.1136\/bmj.321.7261.624.","journal-title":"BMJ"},{"key":"2246_CR11","first-page":"73","volume-title":"MECC Monograph","author":"G Rennert","year":"2006","unstructured":"Rennert G: Breast Cancer Chapter 8. MECC Monograph. Edited by: Freedman LS, Edwards BK, Ries LA, Young JL. 2006, Bethesda: NIH Pub. No. 06-5873, 73-81."},{"key":"2246_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cancergencyto.2003.09.020","volume":"151","author":"A Hadjisavvas","year":"2004","unstructured":"Hadjisavvas A, Charalambous E, Adamou A, Neuhausen SL, Christodoulou CG, Kyriacou K: Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation. Cancer Genet Cytogenet. 2004, 151: 152-156. 10.1016\/j.cancergencyto.2003.09.020.","journal-title":"Cancer Genet Cytogenet"},{"key":"2246_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1399-0004.2007.00747.x","volume":"71","author":"M Loizidou","year":"2007","unstructured":"Loizidou M, Marcou Y, Anastasiadou V, Newbold R, Hadjisavvas A, Kyriacou K: Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early onset breast cancer in Cyprus. Clin Genet. 2007, 71: 165-170. 10.1111\/j.1399-0004.2007.00747.x.","journal-title":"Clin Genet"},{"key":"2246_CR14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","unstructured":"Anglian Breast Cancer Study Group: Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer. 2000, 83: 1301-8. 10.1054\/bjoc.2000.1407.","journal-title":"Br J Cancer"},{"key":"2246_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nrc1475","volume":"4","author":"T Rastogi","year":"2004","unstructured":"Rastogi T, Hildesheim A, Sinha R: Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer. 2004, 4: 909-917. 10.1038\/nrc1475.","journal-title":"Nat Rev Cancer"},{"key":"2246_CR16","first-page":"189","volume-title":"Cancer Epidemiology: Principles and Methods","author":"I dos Santos Silva","year":"1999","unstructured":"dos Santos Silva I: Case-control studies. Cancer Epidemiology: Principles and Methods. Edited by: dos Santos Silva I. Lyon. 1999, IARC Press, 189-212."},{"issue":"5","key":"2246_CR17","doi-asserted-by":"publisher","first-page":"R10","DOI":"10.1186\/bcr454","volume":"4","author":"M Ebrahimi","year":"2002","unstructured":"Ebrahimi M, Vahdaninia M, Montazeri A: Risk factors for breast cancer in Iran: a case-control study. Breast Cancer Res. 2002, 4 (5): R10-10.1186\/bcr454.","journal-title":"Breast Cancer Res"},{"key":"2246_CR18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/oxfordjournals.epirev.a036096","volume":"15","author":"DJ Hunter","year":"1993","unstructured":"Hunter DJ, Willett WC: Diet, body size, and breast cancer. Epidemiol Rev. 1993, 15: 110-132.","journal-title":"Epidemiol Rev"},{"key":"2246_CR19","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","volume":"358","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2001","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001, 358: 1389-1399. 10.1016\/S0140-6736(01)06524-2.","journal-title":"Lancet"},{"key":"2246_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1023\/B:JOMG.0000048770.90334.3b","volume":"9","author":"D Thompson","year":"2004","unstructured":"Thompson D, Easton D: The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia. 2004, 9: 221-236. 10.1023\/B:JOMG.0000048770.90334.3b.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2246_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1582-4934.2005.tb00350.x","volume":"9","author":"RG Dumitrescu","year":"2005","unstructured":"Dumitrescu RG, Cotarla I: Understanding breast cancer risk - where do we stand in 2005?. J Cell Mol Med. 2005, 9: 208-221. 10.1111\/j.1582-4934.2005.tb00350.x.","journal-title":"J Cell Mol Med"},{"key":"2246_CR22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev. 1993, 15: 36-47.","journal-title":"Epidemiol Rev"},{"key":"2246_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.epirev.a036118","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Horn-Ross PL: Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev. 1993, 15: 7-16.","journal-title":"Epidemiol Rev"},{"key":"2246_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/bjc.1981.168","volume":"44","author":"DJ Ferguson","year":"1981","unstructured":"Ferguson DJ, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the \"resting\" human breast. Br J Cancer. 1981, 44: 177-181.","journal-title":"Br J Cancer"},{"key":"2246_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.epirev.a036102","volume":"15","author":"MC Pike","year":"1993","unstructured":"Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993, 15: 17-35.","journal-title":"Epidemiol Rev"},{"key":"2246_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/jnci\/92.4.302","volume":"92","author":"L Lipworth","year":"2000","unstructured":"Lipworth L, Bailey LR, Trichopoulos D: History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst. 2000, 92: 302-312. 10.1093\/jnci\/92.4.302.","journal-title":"J Natl Cancer Inst"},{"key":"2246_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","volume":"360","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2002","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002, 360: 187-195. 10.1016\/S0140-6736(02)09454-0.","journal-title":"Lancet"},{"key":"2246_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0304-3835(94)03681-8","volume":"90","author":"J Russo","year":"1995","unstructured":"Russo J, Russo IH: The etiopathogenesis of breast cancer prevention. Cancer Lett. 1995, 90: 81-89. 10.1016\/0304-3835(94)03681-8.","journal-title":"Cancer Lett"},{"key":"2246_CR29","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/1097-0142(19850901)56:5<1206::AID-CNCR2820560541>3.0.CO;2-9","volume":"56","author":"BE Henderson","year":"1985","unstructured":"Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC: Do regular ovulatory cycles increase breast cancer risk?. Cancer. 1985, 56: 1206-1208. 10.1002\/1097-0142(19850901)56:5<1206::AID-CNCR2820560541>3.0.CO;2-9.","journal-title":"Cancer"},{"key":"2246_CR30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet. 1997, 350: 1047-1059. 10.1016\/S0140-6736(97)08233-0.","journal-title":"Lancet"},{"key":"2246_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","unstructured":"Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333. 10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"key":"2246_CR32","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"RT Chlebowski","year":"2003","unstructured":"Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr M, Thomson CA, Khandekar J, Petrovitch H, McTiernan A, for the WHI Investigators: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomised trial. JAMA. 2003, 289: 3243-3253. 10.1001\/jama.289.24.3243.","journal-title":"JAMA"},{"key":"2246_CR33","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","volume":"360","author":"V Beral","year":"2002","unstructured":"Beral V, Banks E, Reeves G: Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 2002, 360: 942-944. 10.1016\/S0140-6736(02)11032-4.","journal-title":"Lancet"},{"key":"2246_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","volume":"362","author":"V Beral","year":"2003","unstructured":"Beral V, Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003, 362: 419-427. 10.1016\/S0140-6736(03)14596-5.","journal-title":"Lancet"},{"key":"2246_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"RK Ross","year":"2000","unstructured":"Ross RK, Paganini-Hill A, Wan PC, Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000, 92: 328-332. 10.1093\/jnci\/92.4.328.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-447\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:13:28Z","timestamp":1630613608000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-447","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,23]]},"assertion":[{"value":"23 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"447"}}